Electronic Decision Support Using Glucose Sensor Data for Type 2 Diabetes
Studies a computer tool using glucose sensor data for adults with insulin-treated type 2 diabetes.
Key facts
- Who runs it
- HealthPartners Institute
- Where
- Minneapolis, United StatesSee the site
- Trial code
- Registry title
- Clinical Decision Support With Continuous Glucose Monitoring Data for Managing Type 2 Diabetes
- Status
- Enrolling by invitation
- People taking part
- 150 people, planned
- Started
- 4 Mar 2026
- Expected to end
- Jul 2028
- Type of study
- Observational
- Treatments tested
- Continuous Glucose Monitoring Clinical Decision Support
- Record updated
- 10 July 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with type 2 diabetes who use insulin and a continuous glucose monitor, and whose blood sugar is above the target.
- Age
- 18 to 75 years
- Sex
- All sexes can join.
- Disease stage
- Type 2 diabetes with A1c greater than 7.5% (58 mmol/mol).
- Earlier treatment
- Must be on insulin therapy and use CGM (continuous glucose monitoring) to check blood sugar.
- Biomarker or test result
- A1c greater than 7.5% (58 mmol/mol).
Main reasons for not taking part
- Pregnancy
- Use of an insulin pump or automated insulin delivery system
- Active cancer (other than nonmelanoma skin cancer or low-grade prostate cancer followed with observation)
- Cognitive barriers requiring a surrogate or caregiver to manage insulin
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Type 2 diabetes
- A1c greater than 7.5%
- On insulin therapy
- Use CGM for glycemic monitoring
Who cannot take part
- Active cancer (other than nonmelanoma skin cancer or low-grade prostate cancer being followed with observation)
- Pregnancy
- Use of insulin pump or automated insulin delivery system
- Cognitive barriers requiring assistance of a surrogate or caregiver for insulin management
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
Where in United States
- HealthPartners Medical GroupMinneapolis, United StatesEnrolling by invitation
About the trial
What the trial wants to find out
The goal of this project is to see if an electronic health record (EHR)-based smart order set with continuous glucose monitoring data to provide decision support can improve blood sugar management in people with type 2 diabetes (T2D) using insulin.
Treatments tested
- Continuous Glucose Monitoring Clinical Decision Support
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Translating Continuous Glucose Monitoring (CGM) Data Into Action to Improve Management of Insulin-Treated T2D in Primary Care
- Plain-language title
- Electronic Decision Support Using Glucose Sensor Data for Type 2 DiabetesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 13 November 2026.
- Fit questions
- Built from NCT07394075, who can take part
- Record updated
- 10 July 2026